Michael Vasconcelles - Sep 13, 2024 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
/s/ Teresa Bair, Attorney-in-fact for Michael Vasconcelles
Stock symbol
KURA
Transactions as of
Sep 13, 2024
Transactions value $
$0
Form type
4
Date filed
9/17/2024, 04:10 PM
Previous filing
Feb 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +52K $0.00 52K Sep 13, 2024 Common Stock 52K $20.88 Direct F1
transaction KURA Option to purchase common stock Award $0 +17.3K $0.00 17.3K Sep 13, 2024 Common Stock 17.3K $20.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in three equal annual installments commencing on the one year anniversary of the date of grant.
F2 This option vests in full on the one year anniversary of the date of grant.